Edition:
United Kingdom

Ludwig Burger

Jeff Mason is a White House Correspondent for Reuters and the 2016-2017 president of the White House Correspondents’ Association. He was the lead Reuters correspondent for President Barack Obama's 2012 campaign and interviewed the president at the White House in 2015. Jeff has been based in Washington since 2008, when he covered the historic race between Obama, Hillary Clinton and John McCain. Jeff started his career in Frankfurt, Germany, where he covered the airline industry before moving to Brussels, Belgium, where he covered the European Union. He is a Colorado native, proud graduate of Northwestern University and former Fulbright scholar.

Twitter handle: @jeffmason1

05 Oct 2017

Doubts growing whether Clariant can seal Huntsman deal

FRANKFURT/LONDON Doubts are growing among Clariant investors whether the Swiss chemicals maker will be able to drive through a $20 billion merger with Huntsman Corp in the face of opposition from an activist investor.

26 Sep 2017

EU drugs watchdog warns of staff exodus if move from London botched

FRANKFURT Europe's drugs regulator warned on Tuesday it could lose more than 70 percent of it staff, making it unable to function, if politicians pick the wrong new home for the London-based agency.

19 Sep 2017

Bayer says needs more time for Monsanto deal approval

MONHEIM, Germany German drugs and pesticides group Bayer said on Tuesday it was now likely to be early next year before it can complete its $66 billion deal to acquire U.S. group Monsanto , later than previously expected.

19 Sep 2017

Bayer muss sich bei Monsanto-Übernahme gedulden

Monheim Bayer kann die rund 66 Milliarden Dollar schwere Übernahme des US-Saatgutriesen Monsanto nicht so schnell über die Bühne bringen wie erhofft.

15 Sep 2017

Samsung Bioepis wins EU endorsement for first Herceptin copy

SEOUL/FRANKFURT European regulators have for the first time recommended approval of a copy of Swiss drugmaker Roche's blockbuster breast cancer drug Herceptin, made by South Korea's Samsung Bioepis Co Ltd.

08 Sep 2017

Germany's Merck hires JP Morgan to sell consumer health

FRANKFURT/LONDON Germany's Merck KGaA has hired JP Morgan to sell its consumer health business, which includes brands such as Seven Seas vitamins and could be worth around $4.5 billion.

05 Sep 2017

Germany's Merck considers sale of consumer health business

FRANKFURT/COLOGNE Germany's Merck KGaA is considering selling its consumer healthcare business which has sales of $1 billion a year to help fund more research into prescription drugs and amid declines in the company's separate liquid crystal business.

01 Sep 2017

Bain, Cinven name industry veteran Albrecht as Stada CEO

FRANKFURT Private equity firms Bain and Cinven, the buyout firms that have taken control of Stada , picked generic drug industry veteran Claudio Albrecht as the German group's fourth chief executive in 15 months.

28 Aug 2017

ProSieben looking for investors in TV production, e-commerce units

FRANKFURT ProSiebenSat.1 Media SE said it was looking for possible external investors to back its content production and digital commerce businesses, potentially via separate stock market listings.

27 Aug 2017

Bayer, J&J in frame for bigger anti-clotting market opportunity

FRANKFURT Bayer and Johnson & Johnson's blockbuster clot prevention drug Xarelto was shown to cut the risk of potentially deadly strokes and heart attacks in patients with severe atherosclerosis by 24 percent, raising the prospects of billions more in sales.

  • Europe
  • U.S.
  • Asia
  • Sectors
Stock Search
FTSE 100 7,529.94 + 2.97 +0.04%
DAX 13,020.00 + 16.30 +0.13%
CAC 40 5,372.03 + 9.15 +0.17%
TR Europe 184.88 -0.98 -0.53%
GBP/USD 1.3174 -0.56%
GBP/EUR 1.1209 -0.18%
EUR/USD 1.1752 -0.36%
Gold 1,283.10 -16.80 -1.29%
Oil 51.64 -0.23 -0.44%
Corn 349.75 -0.75 -0.21%